EGFR and thyroid gland papillary carcinoma: MIG6 inactivation can be the result of loss of heterozygosity or focal deletion of ERRFI1, as reported in EGFR-amplified glioblastoma [129, 132, 185], or promoter methylation, as found in papillary thyroid carcinoma [186].